Arena/Pfizer Deal History & Licensing Activity
Arena/Pfizer is a life sciences. Over the past three years, Arena/Pfizer has been involved in 2 licensing and acquisition transactions, with a primary focus on Vaccines (2 deals). The company currently has 50 active clinical trials, primarily in Solid Tumors.
Deals (12mo)
0
Active Trials
50
Top Modality
Vaccines
Focus Area
Solid Tumors
Arena/Pfizer Recent Deal Activity
Licensing, acquisition, and partnership transactions involving Arena/Pfizer in the past 12 months.
| Asset | Partner | Modality | Phase | Type | Date |
|---|---|---|---|---|---|
| RSV vaccine | GSK | Vaccines | Unknown | license | Jun 2025 |
Arena/Pfizer Pipeline Focus
Therapeutic areas and modalities where Arena/Pfizer is most active based on deal history and clinical trial data.
Therapeutic Areas
Arena/Pfizer Clinical Pipeline
Arena/Pfizer has 50 active clinical trials across 5 development phases.
13
Unknown
2
Not Applicable
16
Phase 1
14
Phase 2
5
Phase 3
See How Your Asset Matches Arena/Pfizer's Portfolio
Use our deal calculator to benchmark upfront payments, milestones, and royalties for Solid Tumors assets — powered by data from 3,500+ real biopharma transactions.
Related Intelligence
Vaccines Benchmarks
Upfront, milestone, and royalty benchmarks for vaccines deals
S1pModulator Benchmarks
Upfront, milestone, and royalty benchmarks for s1pmodulator deals
Deal Pulse
Track the latest biopharma licensing and acquisition deals across all therapeutic areas
All Company Profiles
Browse 850+ biotech and pharma company profiles with deal history and pipeline data
2026 Deal Benchmarks Report
Industry-wide analysis of deal terms, trends, and market dynamics
About Arena/Pfizer Licensing & Deal Activity
Arena/Pfizer is a life sciences company that has been actively engaged in licensing transactions across the biopharma landscape. With 2 deals over the past three years, Arena/Pfizer ranks among the actively acquisitive companies tracked by Ambrosia Ventures.
Key therapeutic areas of focus for Arena/Pfizer include Solid Tumors (16 deals and trials), Hematological Malignancies (5 deals and trials), Infectious (3 deals and trials), and Autoimmune (3 deals and trials). In terms of modality, Arena/Pfizer has shown particular interest in vaccines, s1pmodulator.
Ambrosia Ventures tracks deal terms, pipeline data, patent expirations, and competitive positioning for Arena/Pfizer and 850+ other biopharma companies. Use our deal calculator to benchmark your asset against Arena/Pfizer's historical deal terms, or explore all company profiles to find the best partner match for your pipeline.